Ionetix and Atonco sign partnership for alpha radiopharmaceutical manufacturing

Ionetix and Atonco signed a partnership agreement for GMP manufacturing and supply of radiopharmaceuticals for Atonco's bladder cancer clinical studies and commercialization in the US.

“We are very excited about the partnership with Atonco, which will allow us to actively collaborate in its clinical development program and commercialization in the United States.”atonco-pharma.com

• 1 source
• atonco-pharma.comIonetix & Atonco Sign Partnership for Alpha Radiopharmaceutical Manufacturingadmin27Mar 31, 2022

Summarized from public sources; check the original articles before acting on it.